Introduction
Since 13C NM R chemical shifts are sensitive towards structural changes, 13C N M R spectroscopy represents a powerful technique for m etabolic studies. Such investigations have been perform ed with cell suspensions [1, 2 ] or mouse livers placed within the NM R tube [3, 4] . Due to the low con centration of the compounds and the low natural abundance of the 13C isotope (1.1%), 13C -enriched substrates are required.
We report herein a new technique for the in vestigation of drug metabolism. M etabolite form a tion in an isolated perfused rat liver is detected in the vascular perfusate by continuous flow ,3C N M R spectroscopy.
Phenacetin is well known to exhibit an extensive first pass metabolism [5] [5] which after ethylation of the phenolic function, reduction and acetylation is transform ed to the product wanted. Figure 1 shows the N M R spectra of ,3C-enriched phenacetin in C D 2C12.
Biological System
Isolated perfused rat liver with a fluorocarbon (perfluorotributylamine, 20% w/v; FC -43R, G reen Cross Corp., Japan), as artificial oxygen carrier has 2. Ac2 0
. = 91 */. ,3C Scheme 2 been used as a biological system that is well controlled and allows investigation of the first pass metabolism [7] .
Pretreatment of the animals with phenobarbital, a specific cytochrome-P 450 inducing drug enhances the tum-over-rate of xenobiotics in the liver.
Experiments using HPLC revealed that the metabolism of phenacetin in this system follows strictly first order kinetics and the rate is enhanced 3 -5 fold by the phenobarbital pretreatment (Fig. 3) .
Perfusion of the isolated rat liver with a synthetic medium (FC-43R) has been perform ed in a flow controlled recirculating system sim ilar to the method used by Schimassek [8 ] . The perfluorotributylamine suspension was constantly equilibrated with 95% 0 2/5% C 0 2 in a film oxygenator.
250-300 g liver donor rats (male, SpragueDewley) pretreated for three days with pheno barbital (80 |ig/g b.w .i.p.) were housed with free access to food and water. Operations were per- formed between 8 -1 0 a.m. under light, ether anesthesia. After canulation of the portal vein, perfusion was started immediately, the liver excised and transferred to the perfusion chamber.
Venous flow, arterial pressure, tem perature, pH, 0 2-consumption, glucose consumption, lactate/ pyruvate ratio and bile flow were constantly con trolled (Fig. 3) . These param eters were shown to be stable for a period of at least 3 h.
Continuous flow I3C N M R spectroscopy
Based on the experience with the registration of continuous flow 'H-NM R-spectra [9, 10] a l3C-NMR flow cell has been developed. The N M Rmeasuring-cell consists of a U -shaped glass-tube; the measuring coil and the decoupling coil being mantled at one side. To inhibit coagulation, the inner glass-walls were silylated.
As shown in the schematic diagram (Fig. 3) , the NMR flow cell was placed in a venous bypass circuit (total volume 32 ml). At a flow-rate of 1 ml/min, the sensitivity and resolution of test NMR spectra approached conventional routinespectra. Higher flow-rates resulted in a dram atic decrease of signal intensity and increase of half width. Due to the experimental design and the different flow-rates in the systemic circuit ( olite concentration in the NM R-and systemic circuits. Therefore, basically two measuring modes are possible:
1. Continuous monitoring produces results with an inherent delay-time of 15 min. 2. The actual data are obtained by increasing the NM R flow rate during the intervals between two measurements.
Results and Discussion
A representative sequence of N M R spectra of a perfusion experiment is dem onstrated in Fig. 4 . Each spectrum consists of 3000 scans with a total acquisition-time of 17 min. D uring the waitinginterval of 5 min between two measurem ents, the concentration ratio in the N M R-circuit is adjusted to the systemic circuit by increasing the flow rate to 10m l/m in. In Fig. 4 The results presented show that it is possible to obtain continuous flow 13C NM R spectra of metabolic events. The still low sensitivity (10-3 m) of the continuous flow i3C N M R spectroscopy is in part (for metabolites) compensated by the induction of the drug metabolising enzymes of the biological system used. Currently we study new probehead designs to achieve an increase in sensitivity. By reducing the void volume of the N M R circuit the time delay between m etabolic events and detection will be reduced. Thus, we do expect that in further experiments the drug concentrations may be lowered to a normal therapeutical range.
